A Prospective Study on Incidence of Febrile Neutropenia and Impact of Prophylactic G-CSF Use in Patients Receiving Moderate to High Intensity Chemotherapy
Febrile neutropenia (FN) remains a complication of myelosuppressive chemotherapy during granulocyte colony-stimulating factor (G-CSF) prophylaxis. This six-month, single-centre prospective observational study enrolled 130 adults consecutively at KIMS Hospital, Secunderabad, to describe FN and hospitalization during moderate-or high-intensity chemotherapy with prophylactic G-CSF. The study recorded FN using a temperature threshold of 38.3°C and concurrent absolute neutrophil count below 500 cells/mm³. Sixty-four patients received moderate-intensity chemotherapy and 66 received high-intensity chemotherapy. Seven patients developed FN (5.38%), and 20 were hospitalized during treatment (15.38%). The study summary identified seven hospitalized patients who met the FN criteria. FN and hospitalization represent distinct outcomes in this cohort. The 5.38% figure describes observed FN during prophylaxis. Estimating the effect of G-CSF would require a comparable group without prophylaxis. The findings provide a centre-specific estimate for this treated cohort.
Authors
- Dr. Sabahat Sakina
- Deeti Lakshmi Prasanna
- Dolla Raj Kumar
- G. Surya Prakash Reddy1
- Elarpu Preethi
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2026-11-19
- DOI
- https://doi.org/10.5281/zenodo.24374650
- Primary Topic
- Neutropenia and Cancer Infections
- Type
- article
- Field-Weighted Citation Impact
- 0.00